NEW ENTERPRISE ASSOCIATES 13 LP Insider Trading $PHAS PhaseBio Pharmaceuticals Inc
Get free email notifications about insider trading for NEW ENTERPRISE ASSOCIATES 13 LP.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of NEW ENTERPRISE ASSOCIATES 13 LP. NEW ENTERPRISE ASSOCIATES 13 LP is 10% Owner in PhaseBio Pharmaceuticals Inc ($PHAS) and 10% Owner in GLYCOMIMETICS INC ($GLYC) and 10% Owner in Workday, Inc. ($WDAY) and 10% Owner in AEROHIVE NETWORKS, INC ($HIVE) and 10% Owner in BOX INC ($BOX) and 10% Owner in Millennial Media Inc. ($MM) and 10% Owner in Care.com Inc ($CRCM) and 10% Owner in Clovis Oncology, Inc. ($CLVS) and 10% Owner in Roka BioScience, Inc. ($ROKA) and 10% Owner in Cloudflare, Inc. ($NET) and 10% Owner in Omthera Pharmaceuticals, Inc. ($OMTH) and Director in Omthera Pharmaceuticals, Inc. ($OMTH) and 10% Owner in Ra Pharmaceuticals, Inc. ($RARX) and 10% Owner in TESARO, Inc. ($TSRO) and 10% Owner in Sprout Social, Inc. ($SPT) and 10% Owner in CVENT INC ($CVT) and 10% Owner in Dermira, Inc. ($DERM) and 10% Owner in Epizyme, Inc. ($EPZM) and 10% Owner in RHYTHM PHARMACEUTICALS, INC. ($RYTM).
NEW ENTERPRISE ASSOCIATES 13 LP in PhaseBio Pharmaceuticals Inc
Trading Symbol: PHASIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of NEW ENTERPRISE ASSOCIATES 13 LP: 10% Owner
Holdings: 4,841,634 shares
Latest Transaction: Oct 24 2018
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of NEW ENTERPRISE ASSOCIATES 13 LP in PhaseBio Pharmaceuticals Inc
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, HIVE, BOX, CRCM, NET, CLVS, CVT, DERM, EPZM, GLYC, MM, OMTH, PHAS, RARX, RYTM, ROKA, SPT, TSRO, WDAY
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Oct 24 2018 | PHAS | PhaseBio Pharmaceu ... | NEW ENTERPRISE ASSOCIATES 13 L ... | 10% Owner | Option Exercise | C | 0.00 | 1,124,301 | 0 | 0 | |
Oct 24 2018 | PHAS | PhaseBio Pharmaceu ... | NEW ENTERPRISE ASSOCIATES 13 L ... | 10% Owner | Option Exercise | C | 0.00 | 437,706 | 0 | 0 | |
Oct 24 2018 | PHAS | PhaseBio Pharmaceu ... | NEW ENTERPRISE ASSOCIATES 13 L ... | 10% Owner | Option Exercise | S | 0.00 | 4,349 | 0 | 437,706 | |
Oct 24 2018 | PHAS | PhaseBio Pharmaceu ... | NEW ENTERPRISE ASSOCIATES 13 L ... | 10% Owner | Option Exercise | X | 0.00 | 181,190 | 0 | 442,055 | |
Oct 24 2018 | PHAS | PhaseBio Pharmaceu ... | NEW ENTERPRISE ASSOCIATES 13 L ... | 10% Owner | Option Exercise | X | 0.12 | 181,190 | 21,743 | 0 | |
Oct 24 2018 | PHAS | PhaseBio Pharmaceu ... | NEW ENTERPRISE ASSOCIATES 13 L ... | 10% Owner | Option Exercise | C | 0.00 | 3,279,627 | 0 | 0 | |
Oct 24 2018 | PHAS | PhaseBio Pharmaceu ... | NEW ENTERPRISE ASSOCIATES 13 L ... | 10% Owner | Option Exercise | S | 0.00 | 1,177 | 0 | 3,279,627 | |
Oct 24 2018 | PHAS | PhaseBio Pharmaceu ... | NEW ENTERPRISE ASSOCIATES 13 L ... | 10% Owner | Option Exercise | X | 0.00 | 49,030 | 0 | 3,280,804 | |
Oct 24 2018 | PHAS | PhaseBio Pharmaceu ... | NEW ENTERPRISE ASSOCIATES 13 L ... | 10% Owner | Option Exercise | X | 0.12 | 49,030 | 5,884 | 0 | |
Oct 24 2018 | PHAS | PhaseBio Pharmaceu ... | NEW ENTERPRISE ASSOCIATES 13 L ... | 10% Owner | Buy | P | 5.00 | 1,800,000 | 9,000,000 | 6,641,634 | 4.8 M to 6.6 M (+37.18 %) |
Oct 24 2018 | PHAS | PhaseBio Pharmaceu ... | NEW ENTERPRISE ASSOCIATES 13 L ... | 10% Owner | Buy | C | 0.00 | 4,841,634 | 0 | 4,841,634 | 0 to 4.8 M |
Page: 1